View in EDS HTML Full Text PDF Full Text

End-of-Induction Response and Tolerability of High-Risk Neuroblastoma Treated with Chemoimmunotherapy-Modified N7 Regimen with Dinutuximab Beta.

Saved in:
Bibliographic Details
Title: End-of-Induction Response and Tolerability of High-Risk Neuroblastoma Treated with Chemoimmunotherapy-Modified N7 Regimen with Dinutuximab Beta.
Authors: Lu ER; Department of Paediatrics and Adolescent Medicine, Hong Kong Children's Hospital, Hong Kong, China.; Department of Paediatrics and Adolescent Medicine, School of Clinical Medicine, LKS Faculty of Medicine, The University of Hong Kong, Hong Kong, China., Hoo CPL; Department of Paediatrics and Adolescent Medicine, Hong Kong Children's Hospital, Hong Kong, China., Cheung HM; Nuclear Medicine Unit, Department of Diagnostic and Interventional Radiology, Queen Elizabeth Hospital, Hong Kong, China., Wong IWC; Nuclear Medicine Unit, Department of Diagnostic and Interventional Radiology, Queen Elizabeth Hospital, Hong Kong, China., Fung KFK; Department of Radiology, Hong Kong Children's Hospital, Hong Kong, China., Chang SLY; Department of Paediatrics and Adolescent Medicine, Hong Kong Children's Hospital, Hong Kong, China., Lee ACW; Department of Paediatrics and Adolescent Medicine, Hong Kong Children's Hospital, Hong Kong, China., Fu ECH; Department of Paediatrics and Adolescent Medicine, Hong Kong Children's Hospital, Hong Kong, China., Ku DTL; Department of Paediatrics and Adolescent Medicine, Hong Kong Children's Hospital, Hong Kong, China., Yau JPW; Department of Paediatrics and Adolescent Medicine, Hong Kong Children's Hospital, Hong Kong, China., Shing MMK; Department of Paediatrics and Adolescent Medicine, Hong Kong Children's Hospital, Hong Kong, China., Mak CYK; Department of Paediatrics and Adolescent Medicine, Hong Kong Children's Hospital, Hong Kong, China., Liu APY; Department of Paediatrics and Adolescent Medicine, Hong Kong Children's Hospital, Hong Kong, China.; Neuro-Oncology Section, Hospital for Sick Children, Toronto, ON M5G 1X8, Canada., Chan GCF; Department of Paediatrics and Adolescent Medicine, Hong Kong Children's Hospital, Hong Kong, China.
Source: Cancers [Cancers (Basel)] 2026 Mar 23; Vol. 18 (6). Date of Electronic Publication: 2026 Mar 23.
Publication Type: Journal Article
Journal Info: Publisher: MDPI Country of Publication: Switzerland NLM ID: 101526829 Publication Model: Electronic Cited Medium: Print ISSN: 2072-6694 (Print) Linking ISSN: 20726694 NLM ISO Abbreviation: Cancers (Basel) Subsets: PubMed not MEDLINE
Database: MEDLINE Ultimate
Full text is not displayed to guests.
FullText Links:
  – Type: pdflink
Text:
  Availability: 1
Header DbId: mdl
DbLabel: MEDLINE Ultimate
An: 41899628
AccessLevel: 2
PubType: Academic Journal
PubTypeId: academicJournal
PreciseRelevancyScore: 0
IllustrationInfo
Items – Name: Title
  Label: Title
  Group: Ti
  Data: End-of-Induction Response and Tolerability of High-Risk Neuroblastoma Treated with Chemoimmunotherapy-Modified N7 Regimen with Dinutuximab Beta.
– Name: Author
  Label: Authors
  Group: Au
  Data: <searchLink fieldCode="AU" term="%22Lu+ER%22">Lu ER</searchLink>; Department of Paediatrics and Adolescent Medicine, Hong Kong Children's Hospital, Hong Kong, China.; Department of Paediatrics and Adolescent Medicine, School of Clinical Medicine, LKS Faculty of Medicine, The University of Hong Kong, Hong Kong, China.<br /><searchLink fieldCode="AU" term="%22Hoo+CPL%22">Hoo CPL</searchLink>; Department of Paediatrics and Adolescent Medicine, Hong Kong Children's Hospital, Hong Kong, China.<br /><searchLink fieldCode="AU" term="%22Cheung+HM%22">Cheung HM</searchLink>; Nuclear Medicine Unit, Department of Diagnostic and Interventional Radiology, Queen Elizabeth Hospital, Hong Kong, China.<br /><searchLink fieldCode="AU" term="%22Wong+IWC%22">Wong IWC</searchLink>; Nuclear Medicine Unit, Department of Diagnostic and Interventional Radiology, Queen Elizabeth Hospital, Hong Kong, China.<br /><searchLink fieldCode="AU" term="%22Fung+KFK%22">Fung KFK</searchLink>; Department of Radiology, Hong Kong Children's Hospital, Hong Kong, China.<br /><searchLink fieldCode="AU" term="%22Chang+SLY%22">Chang SLY</searchLink>; Department of Paediatrics and Adolescent Medicine, Hong Kong Children's Hospital, Hong Kong, China.<br /><searchLink fieldCode="AU" term="%22Lee+ACW%22">Lee ACW</searchLink>; Department of Paediatrics and Adolescent Medicine, Hong Kong Children's Hospital, Hong Kong, China.<br /><searchLink fieldCode="AU" term="%22Fu+ECH%22">Fu ECH</searchLink>; Department of Paediatrics and Adolescent Medicine, Hong Kong Children's Hospital, Hong Kong, China.<br /><searchLink fieldCode="AU" term="%22Ku+DTL%22">Ku DTL</searchLink>; Department of Paediatrics and Adolescent Medicine, Hong Kong Children's Hospital, Hong Kong, China.<br /><searchLink fieldCode="AU" term="%22Yau+JPW%22">Yau JPW</searchLink>; Department of Paediatrics and Adolescent Medicine, Hong Kong Children's Hospital, Hong Kong, China.<br /><searchLink fieldCode="AU" term="%22Shing+MMK%22">Shing MMK</searchLink>; Department of Paediatrics and Adolescent Medicine, Hong Kong Children's Hospital, Hong Kong, China.<br /><searchLink fieldCode="AU" term="%22Mak+CYK%22">Mak CYK</searchLink>; Department of Paediatrics and Adolescent Medicine, Hong Kong Children's Hospital, Hong Kong, China.<br /><searchLink fieldCode="AU" term="%22Liu+APY%22">Liu APY</searchLink>; Department of Paediatrics and Adolescent Medicine, Hong Kong Children's Hospital, Hong Kong, China.; Neuro-Oncology Section, Hospital for Sick Children, Toronto, ON M5G 1X8, Canada.<br /><searchLink fieldCode="AU" term="%22Chan+GCF%22">Chan GCF</searchLink>; Department of Paediatrics and Adolescent Medicine, Hong Kong Children's Hospital, Hong Kong, China.
– Name: TitleSource
  Label: Source
  Group: Src
  Data: <searchLink fieldCode="JN" term="%22101526829%22">Cancers</searchLink> [Cancers (Basel)] 2026 Mar 23; Vol. 18 (6). <i>Date of Electronic Publication: </i>2026 Mar 23.
– Name: TypePub
  Label: Publication Type
  Group: TypPub
  Data: Journal Article
– Name: TitleSource
  Label: Journal Info
  Group: Src
  Data: <i>Publisher: </i><searchLink fieldCode="PB" term="%22MDPI%22">MDPI </searchLink><i>Country of Publication: </i>Switzerland <i>NLM ID: </i>101526829 <i>Publication Model: </i>Electronic <i>Cited Medium: </i>Print <i>ISSN: </i>2072-6694 (Print) <i>Linking ISSN: </i><searchLink fieldCode="IS" term="%2220726694%22">20726694 </searchLink><i>NLM ISO Abbreviation: </i>Cancers (Basel) <i>Subsets: </i>PubMed not MEDLINE
PLink https://search.ebscohost.com/login.aspx?direct=true&site=eds-live&db=mdl&AN=41899628
RecordInfo BibRecord:
  BibEntity:
    Identifiers:
      – Type: doi
        Value: 10.3390/cancers18061028
    Languages:
      – Code: eng
        Text: English
    Titles:
      – TitleFull: End-of-Induction Response and Tolerability of High-Risk Neuroblastoma Treated with Chemoimmunotherapy-Modified N7 Regimen with Dinutuximab Beta.
        Type: main
  BibRelationships:
    HasContributorRelationships:
      – PersonEntity:
          Name:
            NameFull: Lu ER
      – PersonEntity:
          Name:
            NameFull: Hoo CPL
      – PersonEntity:
          Name:
            NameFull: Cheung HM
      – PersonEntity:
          Name:
            NameFull: Wong IWC
      – PersonEntity:
          Name:
            NameFull: Fung KFK
      – PersonEntity:
          Name:
            NameFull: Chang SLY
      – PersonEntity:
          Name:
            NameFull: Lee ACW
      – PersonEntity:
          Name:
            NameFull: Fu ECH
      – PersonEntity:
          Name:
            NameFull: Ku DTL
      – PersonEntity:
          Name:
            NameFull: Yau JPW
      – PersonEntity:
          Name:
            NameFull: Shing MMK
      – PersonEntity:
          Name:
            NameFull: Mak CYK
      – PersonEntity:
          Name:
            NameFull: Liu APY
      – PersonEntity:
          Name:
            NameFull: Chan GCF
    IsPartOfRelationships:
      – BibEntity:
          Dates:
            – D: 23
              M: 03
              Text: 2026 Mar 23
              Type: published
              Y: 2026
          Identifiers:
            – Type: issn-print
              Value: 2072-6694
          Numbering:
            – Type: volume
              Value: 18
            – Type: issue
              Value: 6
          Titles:
            – TitleFull: Cancers
              Type: main
ResultId 1